Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19

NCT05007522 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Respiratory Infection

Interventions

DRUG: Ketotifen/Indomethacin
DRUG: Placebo

Sponsor

Sen-Jam Pharmaceutical

Collaborators

[object Object]